Royce & Associates’s SYNERGETICS USA, INC. SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-671,774
Closed -$4.41M 1248
2015
Q3
$4.41M Sell
671,774
-223,900
-25% -$1.16M 0.02% 677
2015
Q2
$4.21M Sell
895,674
-73,600
-8% -$357K 0.02% 770
2015
Q1
$5.22M Sell
969,274
-197,600
-17% -$934K 0.02% 739
2014
Q4
$5.08M Sell
1,166,874
-364,275
-24% -$1.31M 0.02% 783
2014
Q3
$5.22M Hold
1,531,149
0.02% 804
2014
Q2
$4.75M Buy
1,531,149
+39,875
+3% +$132K 0.01% 866
2014
Q1
$4.55M Buy
1,491,274
+510,000
+52% +$1.73M 0.01% 902
2013
Q4
$3.55M Buy
981,274
+441,700
+82% +$1.81M 0.01% 964
2013
Q3
$2.46M Buy
539,574
+296,474
+122% +$1.23M 0.01% 1030
2013
Q2
$958K Buy
+243,100
New +$802K ﹤0.01% 1172

Royce & Associates's SURG Position: Q4 2015 in Review

Royce & Associates sold out of SYNERGETICS USA, INC. (SURG) in Q4 2015, closing a stake of 671,774 shares — an estimated $4.41M sold.

Royce & Associates first reported a position in SURG in Q2 2013 and held it in 10 quarters. The position peaked at $5.22M in Q1 2015. 0 funds tracked by Wall St. Rank hold SURG as of Q4 2015.

  • Royce & Associates reported no remaining SYNERGETICS USA, INC. position as of Q4 2015 after selling out during the quarter.
  • Royce & Associates sold 671,774 SYNERGETICS USA, INC. shares in Q4 2015, an estimated $4.41M.
  • Royce & Associates first reported a position in SYNERGETICS USA, INC. in Q2 2013 and held it in 10 quarters.
  • Royce & Associates's SYNERGETICS USA, INC. position peaked at $5.22M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNERGETICS USA, INC. as of Q4 2015.

Based on Royce & Associates's 13F filing for Q4 2015, filed 9 Feb 2016.